IP Verse

Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. vs Gilead Pharmasset LLC et al.

The detailed information for PTAB case with proceeding number IPR2018-00103 filed by Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al. against Gilead Pharmasset LLC et al. on Oct 25, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2018-00103
Filing Date: Oct 25, 2017
Petitioner: Initiative for Medicines, Access & Knowledge (I-MAK), Inc. et al.
Respondent: Gilead Pharmasset LLC et al.
Status: Institution Denied
Respondent Application Number: 10828753
Respondent Tech Center: 1600
Respondent Patent Number: 7429572
Institution Decision Date: Jun 13, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice of Refund	Aug 3, 2018	PAPER	BOARD
Petitioner's Request for Refund of Post-Institution Fees	Jul 13, 2018	PAPER	PETITIONER
Trial Instituted Document	Jun 13, 2018	PAPER	BOARD
Interference 105,871, Paper 426, Decision on Motions	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Application 10/608,907	Mar 19, 2018	EXHIBIT	PATENT OWNER
Interference 105,981, Paper 687, Decision on Motions	Mar 19, 2018	EXHIBIT	PATENT OWNER
Interference 105,981, Judgment	Mar 19, 2018	EXHIBIT	PATENT OWNER
Patent Owner's Preliminary Response	Mar 19, 2018	PAPER	PATENT OWNER
Interference 105,871, Paper 1007, Decision ¿¿¿ Priority	Mar 19, 2018	EXHIBIT	PATENT OWNER
Interference 105,871, Paper 1008, Judgment	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Publication No. US2010/0316594	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Application 11/854,218	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Pat. No. 7,608,600 B2 - Part 1 of 3	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Pat. No. 7,608,600 B2 - Part 2 of 3	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Pat. No. 7,608,600 B2 - Part 3 of 3	Mar 19, 2018	EXHIBIT	PATENT OWNER
Storer v. Clark, 860 F.3d 1340 (Fed. Cir. 2017)	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Pat. No. 6,753,309	Mar 19, 2018	EXHIBIT	PATENT OWNER
FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir	Mar 19, 2018	EXHIBIT	PATENT OWNER
FDA Approves Gilead¿¿¿s Hepatitis C Drug	Mar 19, 2018	EXHIBIT	PATENT OWNER
Idenix Pharma., LLC et. al. v. Gilead Sciences, C.A. No. 14-846-LPS, D.I. 591 (D. Del. 2018) (JMOL Opinion)	Mar 19, 2018	EXHIBIT	PATENT OWNER
I-MAK: Our People	Mar 19, 2018	EXHIBIT	PATENT OWNER
Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection	Mar 19, 2018	EXHIBIT	PATENT OWNER
F.D.A. Approves Pill to Treat Hepatitis C	Mar 19, 2018	EXHIBIT	PATENT OWNER
US Pat. No. 7,608,597	Mar 19, 2018	EXHIBIT	PATENT OWNER
America¿¿¿s Overspend: How the Pharmaceutical Patent Problem is Fueling High Drug Prices	Mar 19, 2018	EXHIBIT	PATENT OWNER
Notice of Accord Filing Date	Dec 18, 2017	PAPER	BOARD
Patent Owner's Mandatory Notices	Nov 9, 2017	PAPER	PATENT OWNER
Patent Owner Power of Attorney	Nov 9, 2017	PAPER	PATENT OWNER
Power of Attorney	Oct 25, 2017	PAPER	PETITIONER
U.S. Patent No. 7,429,572	Oct 25, 2017	EXHIBIT	PETITIONER
Curriculum Vitae of Joseph M. Fortunak, Ph.D.	Oct 25, 2017	EXHIBIT	PETITIONER
Klecker	Oct 25, 2017	EXHIBIT	PETITIONER
Sommadossi	Oct 25, 2017	EXHIBIT	PETITIONER
McGuigan 1993	Oct 25, 2017	EXHIBIT	PETITIONER
McGuigan 1994	Oct 25, 2017	EXHIBIT	PETITIONER
McAtee	Oct 25, 2017	EXHIBIT	PETITIONER
Pankiewicz	Oct 25, 2017	EXHIBIT	PETITIONER
Britton	Oct 25, 2017	EXHIBIT	PETITIONER
Codington	Oct 25, 2017	EXHIBIT	PETITIONER
Watanabe	Oct 25, 2017	EXHIBIT	PETITIONER
File History Excerpts	Oct 25, 2017	EXHIBIT	PETITIONER
Petition for Inter Partes Review	Oct 25, 2017	PAPER	PETITIONER
Declaration of Joseph M. Fortunak, Ph.D.	Oct 25, 2017	EXHIBIT	PETITIONER